Lars Fruergaard Jørgensen (født 29. november 1966,[1] S... - dofaq.co
Lars Fruergaard Jørgensen (født 29. november 1966,[1] S...Lars Fruergaard Jørgensen (født 29. november 1966,[1] Skals) er en dansk erhvervsmand, der nuværende administrerende direktør for Novo Nordisk. Han overtog stillingen ved årskiftet til 2017 fra Lars Rebien Sørensen.[2][3]
Novo Nordisk missed its diversity targets last year. Its CEO paid the price
Novo Nordisk CEO says he's confident about Wegovy supply, next-generation weight loss drugs
Wegovy sales took a hit this year. Novo's CEO blames off-brand competition
‘There's Only One Semaglutide’: Novo CEO Admits Compounders Are Hurting Weight Loss Business
Novo Nordisk CEO Jorgensen agrees to testify before Senate over U.S. pricing of semaglutide products
Bernie Sanders says Ozempic can be produced for less than $100 a month
Novo Nordisk CEO’s Senate showdown
Denmark wanted advice on handling Trump. It turned to Ozempic’s boss.
MEDIA ADVISORY: Sanders to Lead HELP Com...
Novo Nordisk CEO on Wegovy prices, supplies and compounding
Lars Fruergaard Jørgensen
Leaders With Lacqua: Novo Nordisk CEO Lars Fruergaard Jørgensen
Blame drug 'middlemen' for Ozempic and Wegovy prices, Novo Nordisk CEO tells Congress
Watch full interview with Novo Nordisk CEO Lars Fruergaard Jørgensen
Novo CEO, Sanders to Face Off Over US Prices for Ozempic and Wegovy
Novo Nordisk CEO takes aim at U.S. health system in Ozempic testimony
Novo Nordisk says copycat compounders are hurting Wegovy sales, may take legal action
Novo Nordisk's CEO took the Washington hot seat over Ozempic prices. 3 takeaways from his testimony
'Stop ripping us off': Senate grills Novo Nordisk CEO on weight loss drug pricing
